RWLK - Earnings announcements

Highest quarterly and annual revenue in the history of LifewardCommercial and operational integration complete; synergiesexpected to yield $3 million in annual net savings MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, Feb. 27, 2024 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (DBA Lifeward™), (NASDAQ:LFWD) ("Lifeward" or the "Company"), a global market leader delivering life-changing solutions to revolutionize what is possible in rehabilitation, recovery, and the pursuit of life's passions in the face of physical limitation or disability, today announced its financial results for the three months and full year ended December 31, 2023. Highlights of the Fourth Quarter of 2023 and Early 2024

MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, Feb. 20, 2024 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (DBA Lifeward™), (NASDAQ:LFWD) ("Lifeward" or the "Company"), a global market leader delivering life-changing solutions to revolutionize what is possible in rehabilitation, recovery, and the pursuit of life's passions in the face of physical limitation or disability, today announced that the Company will release its fourth quarter and fiscal year-end 2023 financial results before the markets open on Tuesday, February 27, 2024. Larry Jasinski, Chief Executive Officer, and Michael Lawless, Chief Financial Officer, will host a conference call and live webcast at 8:30 a.m. EST to discuss the f

Record Quarterly Revenue of $4.4 Million Successful Completion of AlterG Acquisition and Significant Progress of Integration Major Advancement in Efforts to Attain Medicare Payment Coverage of Exoskeletons MARLBOROUGH, Mass., BERLIN and YOKNEAM ILLIT, Israel, Nov. 14, 2023 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (NASDAQ:RWLK) ("ReWalk" or the "Company"), a leading provider of innovative technologies that enable mobility and wellness in rehabilitation and daily life for individuals with neurological conditions, today announced its financial results for the three and nine months ended September 30, 2023. Highlights of the Third Quarter of 2023 include: Closing of ReWalk's acquisition o

MARLBOROUGH, Mass., and BERLIN, and YOKNEAM ILLIT, Israel, Nov. 07, 2023 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (NASDAQ:RWLK) ("ReWalk" or the "Company"), a leading provider of innovative technologies that enable mobility and wellness in rehabilitation and daily life for individuals with neurological conditions, today announced that that it has scheduled a conference call for Wednesday, November 8, 2023 at 8:30 a.m. EST, to discuss Medicare's preliminary payment determination for the ReWalk Personal Exoskeleton. On Friday, November 3, the Centers for Medicare & Medicaid Services ("CMS") released an agenda for the upcoming Healthcare Common Procedure Coding System ("HCPCS") meeting on 

MARLBOROUGH, Mass. and BERLIN and YOKNEAM ILIT, Israel, Nov. 07, 2023 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (NASDAQ:RWLK) ("ReWalk" or the "Company") today announced that the Company will release its third quarter 2023 financial results on Tuesday, November 14, 2023, prior to the U.S. financial markets open. Larry Jasinski, Chief Executive Officer, and Michael Lawless, Chief Financial Officer, will host a conference call and live webcast at 8:30 a.m. EST to discuss the financial results. To access the call, analysts and investors may utilize the following: Toll free (U.S.)1-833-316-0561International (U.S)1-412-317-0690Germany0800-6647650Israel1-809-212373Access CodePlease reference the

Revenue in Line with Prior Financial Guidance Continued Progress with CMS in Establishment of Medicare Benefit Category for Exoskeletons Pending Acquisition of AlterG Expected to Contribute to ReWalk Financial Results Starting in Q3'23 MARLBOROUGH, Mass. and BERLIN and YOKNEAM ILLIT, Israel, Aug. 11, 2023 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (NASDAQ:RWLK) ("ReWalk" or the "Company"), a leading provider of innovative technologies that enable mobility and wellness in rehabilitation and daily life for individuals with neurological conditions, today announced its financial results for the three and six months ended June 30, 2023. Highlights of the Second Quarter of 2023 include: Total

Combined Company Expands Patient and Clinician Access to Innovative Rehabilitation Technologies for Home and Clinic Use Transaction Projected to Increase Revenue Growth and Improve Operating Margin, While Reducing Cash Burn Rate MARLBOROUGH, Mass. and BERLIN and YOKNEAM ILLIT, Israel, Aug. 08, 2023 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (NASDAQ:RWLK) ("ReWalk"), a leading provider of innovative technologies that enable mobility and wellness in rehabilitation and daily life for individuals with neurological conditions, today announced the execution of a definitive agreement to acquire AlterG, Inc. ("AlterG"), a leading innovator and provider of Anti-Gravity systems for use in physical a

MARLBOROUGH, Mass. and BERLIN and YOKNEAM ILLIT, Israel, Aug. 03, 2023 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (NASDAQ:RWLK) ("ReWalk" or the "Company") announced that the Company will release its second quarter 2023 financial results before the markets open on Friday, August 11, 2023. Larry Jasinski, Chief Executive Officer, and Michael Lawless, Chief Financial Officer, will host a conference call and live webcast at 8:30 a.m. EDT to discuss the financial results. To access the call, analysts and investors may utilize the following: Toll free (U.S.)1-833-316-0561International (U.S)1-412-317-0690Germany0800-6647650Israel1-80-9212373Access CodePlease reference the "ReWalk Robotics Ltd. Ca

MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, July 05, 2023 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (NASDAQ:RWLK) ("ReWalk" or "the Company"), a leading provider of innovative technologies that enable mobility and wellness in rehabilitation and daily life for individuals with neurological conditions, announced that it will host a conference call and webcast on Tuesday, July 11, 2023 to discuss the recent proposal from the Centers for Medicare & Medicaid Services ("CMS") to include personal exoskeletons in the Medicare benefit category for braces as part of the Calendar Year 2024 Home Health Prospective Payment System Proposed Rule, CMS-1780-P ("Proposed Rule"), released on June 30, 2023.

On-Track Start to Fiscal Year with Progress in Advancing Reimbursement Coverage for Medicare Beneficiaries MARLBOROUGH, Mass. BERLIN and YOKNEAM ILLIT, Israel, May 11, 2023 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (NASDAQ:RWLK) ("ReWalk" or the "Company"), a leading provider of innovative technologies that enable mobility and wellness in rehabilitation and daily life for individuals with neurological conditions, today announced its financial results for the three months ended March 31, 2023. Highlights of the first quarter of 2023 include: Total revenue for the first quarter of 2023 was $1.2 million, as compared to $0.9 million in the first quarter of 2022, up 40%;Gross margin was 46.4%

MARLBOROUGH, Mass. and BERLIN and YOKNEAM ILLIT, Israel, May 03, 2023 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (NASDAQ:RWLK) ("ReWalk" or the "Company") announced that the Company will release its first quarter 2023 financial results before the markets open on Thursday, May 11, 2023. Larry Jasinski, Chief Executive Officer, and Michael Lawless, Chief Financial Officer, will host a conference call and live webcast at 8:30 a.m. EDT to discuss the financial results. To access the call, analysts and investors may utilize the following: Toll free (U.S.)1-833-630-1956International (U.S)1-412-317-1837Germany0800-6647650Israel1-80-9212373Access CodePlease reference the "ReWalk Robotics Ltd. Call"

Strong Conclusion to 2022 – Q4'22 Revenue Highest Since Start of COVID-19 Pandemic Record Quarterly MyoCycle Sales Supplement Improved Exoskeleton Revenue    MARLBOROUGH, Mass. and BERLIN and YOKNEAM ILIT, Israel, Feb. 23, 2023 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (NASDAQ:RWLK) ("ReWalk" or the "Company"), a medical device company that designs, develops, and commercializes innovative technologies that enable mobility and wellness in rehabilitation and daily life for individuals with neurological conditions, today announced its financial results for the three months and full year ended December 31, 2022. Financial highlights and business accomplishments: Revenue for the fourth qua

MARLBOROUGH, Mass. and BERLIN and YOKNEAM ILIT, Israel, Feb. 16, 2023 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (NASDAQ:RWLK) ("ReWalk" or the "Company") today announced that the Company will release its fourth quarter and fiscal year-end 2022 financial results on Thursday, February 23, 2023, at 8:30 AM Eastern time. Larry Jasinski, Chief Executive Officer, and Michael Lawless, Chief Financial Officer, will host a conference call to discuss the results as follows: Time8:30 A.M ESTToll free (U.S.)1-833-630-1956International (U.S)1-412-317-1837Germany0800-6647650Israel1-80-9212373Access CodePlease ask to join into the ReWalk Robotics Ltd. callWebcast (live and replay)https://edge.media-serve

ReWalk Has Submitted the First Case to Medicare Administrative Contractors (MACs) for Coverage and Reimbursement of the ReWalk Exoskeleton for Medicare Beneficiaries   As of November 4th, ReWalk Has Repurchased $0.9 Million of Common Stock Since Initiation of Its Program German Federal Social Court Hearing on November 10th with Ruling Expected Shortly After    MARLBOROUGH, Mass. and BERLIN and YOKNEAM ILIT, Israel, Nov. 07, 2022 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (NASDAQ:RWLK) ("ReWalk" or the "Company"), a leading manufacturer of robotic medical technology for people with lower extremity disabilities, today announced its financial results for the three and nine months ended Sept

MARLBOROUGH, Mass. BERLIN, Germany and YOKNEAM ILIT, Israel, Oct. 31, 2022 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (NASDAQ:RWLK) ("ReWalk" or the "Company") today announced that the Company will release its third quarter 2022 financial results on Monday, November 7, 2022, at 8:30 AM Eastern time. Larry Jasinski, Chief Executive Officer, and Michael Lawless, Chief Financial Officer, will host a conference call to discuss the results as follows: Time8:30 A.M ESTToll free (U.S.)1-833-630-1956International (U.S)1-412-317-1837Germany0800-6647650Israel1-80-9212373Access CodePlease request to be connected to ReWalk Robotics Ltd. callWebcast (live and replay)https://edge.media-server.com/mmc/p/g

Highlights June 8th Milestone Participation at Biannual CMS HCPCS Public Meeting as Part of Efforts to Gain "Artificial Legs" Benefit Category Classification as Prosthetic for ReWalk Device         Has Submitted 510k Application for ReWalk Stairs and Curbs Functionality MARLBOROUGH, Mass. and BERLIN and YOKNEAM ILIT, Israel, Aug. 09, 2022 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (NASDAQ:RWLK) ("ReWalk" or the "Company") today announced its financial results for the three and six months ended June 30, 2022. Highlights of and subsequent to the second quarter of 2022 include: Total revenue for the second quarter of 2022 was $1.6 million, compared to $1.4 million in the second quarter of 2

MARLBOROUGH, Mass. and BERLIN and YOKNEAM ILIT, Israel, Aug. 03, 2022 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (NASDAQ:RWLK) ("ReWalk" or the "Company") today announced that the Company will release its second quarter 2022 financial results on Tuesday, August 9, 2022, at 8:30 AM Eastern time. Larry Jasinski, Chief Executive Officer, and Almog Adar, Director of Finance, will host a conference call to discuss the results as follows: Time8:30 A.M EDTToll free (U.S.)(866) 374-5140International (U.S)(404) 400-0571Germany8001897777Israel4044000571Access Code43100176#Webcast (live and replay)https://edge.media-server.com/mmc/p/fz7je7rr under the ‘Investors' section'. The archived webcast wil

MARLBOROUGH, Mass. and BERLIN and YOKNEAM ILIT, Israel, May 13, 2022 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (NASDAQ:RWLK) ("ReWalk" or the "Company") today announced its financial results for the three months ended March 31, 2022. Highlights of and subsequent to the first quarter of 2022 include: Total revenue for the first quarter of 2022 was $0.9 million, compared to $1.3 million in the first quarter of 2021;Placed on June 8th CMS agenda of the Biannual Healthcare Common Procedure Coding System (HCPCS) meeting that includes benefit category determination for the first time under the new DEMPOS rules. This is based on previous interactions with CMS to determine ReWalk's benefit catego

MARLBOROUGH, Mass. and BERLIN and YOKNEAM ILIT, Israel, May 09, 2022 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (NASDAQ:RWLK) ("ReWalk" or the "Company") today announced that the Company will release its first quarter 2022 financial results on Friday, May 13, 2022, after the U.S. financial markets close.    Larry Jasinski, Chief Executive Officer, and Almog Adar, Director of Finance, will host a conference call to discuss the results as follows: Time4:30 P.M. EDTToll free (U.S.)(844) 423-9889International (U.S)(716) 247-5804Germany08001800658Israel1809457877Access Code6071145Webcast (live and replay)https://edge.media-server.com/mmc/p/9juksp4m under the ‘Investors' section'. The

MARLBOROUGH, Mass. BERLIN and YOKNEAM ILIT, Israel, Feb. 24, 2022 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (NASDAQ:RWLK) ("ReWalk" or the "Company") today announced its financial results for the three and twelve-months ended December 31, 2021. Highlights of and subsequent to the fourth quarter and FY 2021 include: Annual revenue of $6.0 million in 2021 represents 36% year over year growth;Fourth quarter 2021 revenues were $1.2 million, up by 2% compared to previous year quarter;Strong cash position with $88.3 million as of December 31, 2021;New DMEPOS rules issued in December 2021 will advance consideration of the ReWalk benefit category and pricing, andGerman court case on ReWalk Person

MARLBOROUGH, Mass. and BERLIN and YOKNEAM ILIT, Israel, Feb. 21, 2022 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (NASDAQ:RWLK) ("ReWalk" or the "Company") today announced that the Company will release its fourth quarter 2021 financial results on Thursday, February 24, 2022, before the U.S. financial markets open.    Larry Jasinski, Chief Executive Officer, and Ori Gon, Chief Financial Officer, will host a conference call to discuss the results as follows: Time8:30 A.M. ESTToll free (U.S.)(888) 771-4371International (U.S.)(847) 585-4405Germany08 00 101 4676Israel18 09 212 582Access Code50284605Webcast (live and replay)https://edge.media-server.com/mmc/p/ta4v2yfrunder the ‘Investors' section'

MARLBOROUGH, Mass. and BERLIN and YOKNEAM ILIT, Israel, Nov. 05, 2021 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (NASDAQ:RWLK) ("ReWalk" or the "Company") today announced that management will hold its third quarter 2021 earnings call Thursday, November 11, 2021, at 8:30 AM Eastern time.  To access the conference call please dial the following: Toll free (U.S.)(844) 423-9889International (U.S)(716) 247-5804Germany08 00 18 15 287Israel18 09 31 53 62Access Code4692387Webcast (live and replay)https://edge.media-server.com/mmc/p/h495e8p4under the ‘Investors' section'. The archived webcast will be available via the following link https://edge.media-server.com/mmc/p/h495e8p4 or through the

— Second Quarter 2021 Total Revenue of $1.4 million — — Second quarter 2021 marks the fourth consecutive quarter over quarter growth — — Strong balance sheet with $ 64.2 million in cash, as of June 30, 2021— MARLBOROUGH, Mass. and BERLIN and YOKNEAM ILIT, Israel, Aug. 09, 2021 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (NASDAQ:RWLK) ("ReWalk" or the "Company") today announced its financial results for the three and six months ended June 30, 2021. Highlights of and subsequent to the second quarter of 2021 include: Total revenue in the second quarter of 2021 was $1.4 million;Second quarter 2021 marks the fourth consecutive quarter over quarter growth;Gross margin was 51% in the second qu

MARLBOROUGH, Mass. and BERLIN and YOKNEAM ILIT, Israel, Aug. 04, 2021 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (NASDAQ:RWLK) ("ReWalk" or the "Company") today announced that the Company will release its second quarter 2021 financial results on Monday, August 9, 2021, before the U.S. financial markets open. Larry Jasinski, Chief Executive Officer, and Ori Gon, Chief Financial Officer, will host a conference call to discuss the results as follows: Time8:30 A.M ESTToll free (U.S.)(844) 423-9889International (U.S)(716) 247-5804Germany08 00 18 15 287Israel18 09 31 53 62Access Code8287612Webcast (live and replay)https://edge.media-server.com/mmc/p/4oshituiunder the ‘Investors' section'. The arc

— First Quarter 2021 Total Revenue of $1.3 million — — Strong balance sheet with $ 67.4 million in cash, as of March 31, 2021— MARLBOROUGH, Mass. and BERLIN and YOKNEAM ILIT, Israel, May 11, 2021 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (NASDAQ:RWLK) ("ReWalk" or the "Company") today announced its financial results for the three months ended March 31, 2021. Highlights of and subsequent to the first quarter of 2021 include: The Company's total revenue in the first quarter of 2021 was $1.3 million, compared to $0.8 million in the prior year's first quarter;The Company's gross margin was 54% in Q1 of 2021, compared to 49% in Q1 of 2020;The Company's operating expenses were $3.7 million in

— Annual revenue of $4.4 million in 2020 and $1.2 million for the fourth quarter of 2020 — — Continued CMS progress made with issuance of HCPCS Level II Code for ReWalk Exoskeleton enabling an upcoming application for coverage — — Debt repayment and strengthened cash position allowed going concern qualification removal — — Expended German reimbursement contracts with additional insurers — MARLBOROUGH, Mass. and BERLIN, Germany and YOKNEAM ILIT, Israel, Feb. 18, 2021 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) today announced its financial results for the three and twelve-months ended December 31, 2020. Highlights of and subsequent to the fourth